Chau Cheng
Investor Relations Contact at IMMUNOVANT, INC.
Profile
Chau Cheng is currently the Vice President of Investor Relations at Immunovant, Inc. Prior to this, he worked as the Senior Director of Investor Relations at Immunomedics, Inc. from 2004 to 2020.
From 2020 to 2022, he worked as the VP of Investor Relations and Corporate Communications at CytomX Therapeutics, Inc. Dr. Cheng holds a Master's in Business Administration from The Leonard N Stern School of Business.
Chau Cheng active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOVANT, INC. | Investor Relations Contact | - |
Former positions of Chau Cheng
| Companies | Position | End |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Investor Relations Contact | 2022-08-31 |
| IMMUNOMEDICS, INC. | Investor Relations Contact | 2020-11-30 |
Training of Chau Cheng
| The Leonard N Stern School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| IMMUNOVANT, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
- Stock Market
- Insiders
- Chau Cheng
